The Brazil market dominated the LAMEA Portable Ultrasound Bladder Scanner Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$6.43 million by 2031. The Argentina market is showcasing a CAGR of 7.2% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 6% during (2024 - 2031).
The focus on patient-centered care has driven healthcare providers to prioritize technologies that enhance the patient experience. Portable ultrasound bladder scanners offer several advantages, including minimal discomfort, quick and easy assessments, and the ability to perform bedside evaluations without needing patient transportation or specialized facilities. By improving patient comfort and convenience, these devices contribute to higher patient satisfaction levels and better overall healthcare experiences.
Similarly, point-of-care evaluations can be conducted in a variety of clinical settings, such as outpatient clinics, healthcare facilities, hospitals, and home healthcare settings, due to the portability and user-friendliness of portable ultrasound bladder scanners. Healthcare providers can perform real-time bladder volume measurements at the bedside, facilitating prompt diagnosis, treatment decisions, and care planning. This decentralization of diagnostic capabilities aligns with the shift towards value-based care models and promotes greater efficiency in healthcare delivery.
With a growing healthcare budget, the UAE government and private healthcare providers allocate funds to acquire advanced medical technologies to enhance diagnostic capabilities and patient care outcomes. Portable ultrasound bladder scanners are considered essential diagnostic tools in urology departments, emergency rooms, and outpatient clinics with their noninvasive imaging capabilities and point-of-care functionality.
Increased healthcare spending in the UAE drives demand for portable bladder scanners to support timely diagnosis, treatment planning, and patient monitoring. As per the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare. Additionally, UAE's Vision 2040 has healthcare as a priority sector for the UAE government, and the country will continue to be an attractive location for establishing a regional distribution center for healthcare services. Therefore, rising healthcare budget in the region drives the market's growth.
Based on Product, the market is segmented into 2D and 3D. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Verathon Inc. (Roper Technologies, Inc.)
- Infinium Medical, Inc.
- Advin Health Care
- Caresono Technology Co.,Ltd.
- Becton, Dickinson and Company
- ECHO-SON S.A.
- Vitacon AS
Market Report Segmentation
By Product- 2D
- 3D
- Hospitals
- Diagnostic Imaging Centers
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Companies Mentioned
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Verathon Inc. (Roper Technologies, Inc.)
- Infinium Medical, Inc.
- Advin Health Care
- Caresono Technology Co.,Ltd.
- Becton, Dickinson and Company
- ECHO-SON S.A.
- Vitacon AS
Methodology
LOADING...